Abstract
Basal prolactin (PRL) levels and PRL responsiveness to thyrotropin-releasing hormone (TRH) were studied in 10 women with primary empty sella (PES) syndrome (mean age 38.2 yr). Hyperprolactinemia (34 to 72 ng/ml) was found in 5 patients (hyperprolactinemic PES, H-PES), whereas 5 patients showed normal (9.5 to 19 ng/ml) PRL levels (normoprolactinemic PES, N-PES). The results were compared with those obtained in 10 healthy women (mean age 32.8 yr, PRL = 7 to 15 ng/ml) and in 8 women with a PRL-secreting pituitary microadenoma (MA) (mean age 37.5 yr, PRL = 39 to 85 ng/ml). The mean basal levels of PRL were significantly higher in patients with H-PES (50.8 ± 13.2 ng/ml) or MA (64.0 ± 18.3 ng/ml) than in the control group (10.9 ± 2.6 ng/ml, p < 0.02) and in the patients with N-PES (13.9 ± 3.7 ng/ml, p < 0.02). In contrast, the relative maximum response (RMR) of PRL to TRH (peak PRL/basal PRL) was significantly lower in the patients with PES (both H-PES and N-PES) or MA (1.4 ± 0.4, 2.3 ± 0.7 and 1.2 ± 0.2, respectively) than in the control subjects (3.6 ± 1.1; p < 0.02, < 0.05 and < 0.02, respectively). Our results show that the pituitary responsiveness to the acute stimulation with TRH is significantly decreased both in patients with a PRL-secreting pituitary MA and in those with PES. Therefore, the clinical value of the TRH test in distinguishing the PES syndromes from prolactinomas seems to be questionable.
Similar content being viewed by others
References
Foley K.M., Posner J.B. Does pseudotumor cerebri cause the empty sella syndrome? Neurology 25: 565, 1975.
Jordan R.M., Kendall J.W., Kerber C.W. The primary empty sella syndrome. Analysis of the clinical characteristics, radiographic features, pituitary function and cerebrospinal fluid adenohypophysial hormone concentrations. Am. J. Med. 62: 569, 1977.
Brismar K. Prolactin secretion in the empty sella syndrome, in prolactinomas and in acromegaly. Acta Med. Scand. 209: 397, 1981.
Bryner J.R., El Gammal T., Acker J.D., Asch R.H., Greenblatt R.B. Intrasellar subaracnoid herniation or empty sella associated with galactorrhea. Obstet. Gynecol. 51: 198, 1978.
Swanson J.A., Sherman B.M., Van Gilder J.C., Chapter F.K. Coexistent empty sella and prolactin-secreting microadenoma. Obstet. Gynecol. 53: 258, 1979.
Jara-Albarràn A., Bayort J., De Juan M., Benito C. Spontaneous partial empty sella. A study of 41 cases. Exp. Clin. Endocrinol. 83: 63, 1984.
Kleinberg D.L., Noel G.L., Frantz A.G. Galactorrhea: a study of 235 cases including 48 with pituitary tumors. N. Engl. J. Med. 296: 589, 1977.
Foster D.W. Eating disorders: obesity and anorexia nervosa. In: Wilson J.D., Foster D.W. (Eds.), Williams Textbook of Endocrinology, ed. 6. Saunders Company, Philadelphia, 1985, p. 1081.
Chui M., Patel H.M. Computed tomography of sellar and parasellar lesions: indications for metrizamide cysternography. J. Can. Assoc. Radiol. 33: 84, 1982.
Marrama P., Carani C., Celani M.F., Baraghini G.F., Cavani D., Montanini V. ACTH 1–17 effects in psychogenic impotence. Ric. Clin. Lab. 14: 233, 1984.
Marrama P., Montanini V., Celani M.F., Baraghini G.F., Carani C., Cavani D., Negri R., Diazzi G. Further studies on basal immunoreactive luteinizing hormone (LH), serum testosterone and pituitary responsiveness to luteinizing hormone releasing hormone (LHRH) in elderly men. Min. Endocrinol. 9: 1, 1984.
Frantz A.G. Prolactin; N. Engl. J. Med. 298: 201, 1978.
Ridgway E.C., Kourides I.A., Kliman B., Bigos T., Maloof F. Thyrotropin and prolactin pituitary reserve in the “empty sella syndrome”. J. Clin. Endocrinol. Metab. 41: 698, 1975.
Maira G., Anile C., Cioni B., Menini E., Mancini A., De Marinis L., Barbarino A. Relationships between intracranial pressure and diurnal prolactin secretion in primary empty sella. Neuroendocrinology 38: 102, 1984.
Malarkey W.B., Goodenow T.J., Lanese R.R. Diurnal variation of prolactin secretion differentiates pituitary tumors from the primary empty sella syndrome. Am. J. Med. 69: 886, 1980.
Malarkey W.B., Johnson J.C. Pituitary tumors and hyperprolactinemia. Arch. Intern. Med. 136: 40, 1976.
Mendelson W.B., Jacobs L.S., Reichman J.D., Othmer E., Cryer P.E., Trivedi B., Daughaday W.H. Methysergide suppression of sleep-related prolactin secretion and enhancement of sleep-related growth hormone secretion. J. Clin. Invest. 56: 690, 1975.
Eskildsen P.C., Kirkegaard C.B. The influence of thyroid disorders on the dopaminergic regulation of prolactin, thyrotropin and growth hormone. J. Endocrinol. Invest. 8: 427, 1985.
Clemens J.A., Shaar C.J. Control of prolactin secretion in mammals. Fed. Proc. 39: 2588, 1980.
Leong D.A., Frawley L.S., Neill J.D. Neuroendocrine control of prolactin secretion. Ann. Rev. Physiol. 45: 109, 1983.
Farkouh N.H., Packer M.G., Frantz A.G. Large molecular size prolactin with reduced receptor activity in human serum: high proportion in basal states and reduction after thyrotropin-releasing hormone. J. Clin. Endocrinol. Metab. 48: 1026, 1979.
Sinha Y.N., Baxter S.R. Identification of a nonimmunoreactive but highly bioactive form of prolactin in the mouse pituitary by gel electrophoresis. Biochem. Biophys. Res. Commun. 86: 325, 1979.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Celani, M.F., Giambuzzi, G., Simoni, M. et al. Subnormal prolactin responsiveness to thyrotropin-releasing hormone (TRH) in women with primary empty sella syndrome. J Endocrinol Invest 10, 421–425 (1987). https://doi.org/10.1007/BF03348162
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03348162